IGC Pharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
IGC Pharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2010 to Q3 2024.
  • IGC Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 76.6M shares, a 20.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 76.6M +12.9M +20.3% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 75.6M +22.6M +42.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 66.7M +13.6M +25.6% Mar 31, 2024 10-Q 2024-11-12
Q4 2023 63.7M +10.7M +20.1% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 63.7M +10.6M +20.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 53.1M +1.24M +2.39% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 53.1M +2.02M +3.96% Mar 31, 2023 10-K 2024-06-24
Q4 2022 53.1M +2.02M +3.96% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 53.1M +2.02M +3.95% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 51.8M +3.56M +7.37% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 51.1M +3.23M +6.75% Mar 31, 2022 10-K 2023-07-07
Q4 2021 51.1M +9.75M +23.6% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 51M +9.74M +23.6% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 48.3M +7.09M +17.2% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 47.8M +8.51M +21.6% Mar 31, 2021 10-K 2022-06-23
Q4 2020 41.3M +1.73M +4.38% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 41.3M +1.73M +4.38% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 41.2M +1.68M +4.26% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 39.3M -181K -0.46% Mar 31, 2020 10-K 2021-06-14
Q4 2019 39.6M -15.4K -0.04% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 39.6M +5.32M +15.5% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 39.5M +8.47M +27.3% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 39.5M +8.74M +28.4% Mar 31, 2019 10-K 2020-07-13
Q4 2018 39.6M +10.1M +34.2% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 34.2M +6.24M +22.3% Sep 30, 2018 10-Q 2018-10-16
Q2 2018 31M +4.24M +15.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 30.8M +2.49M +8.81% Mar 31, 2018 10-K 2019-06-14
Q4 2017 29.5M -342K -1.15% Dec 31, 2017 10-Q 2018-02-20
Q3 2017 28M +4.05M +16.9% Sep 30, 2017 10-Q 2017-11-17
Q2 2017 26.8M +3.54M +15.2% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 28.3M +5.01M +21.5% Mar 31, 2017 10-K 2018-06-21
Q4 2016 29.8M +12.7M +74.3% Dec 31, 2016 10-Q 2017-02-21
Q3 2016 24M +7.73M +47.7% Sep 30, 2016 10-Q 2016-11-21
Q2 2016 23.3M +8.27M +55.2% Jun 30, 2016 10-Q 2016-08-16
Q1 2016 23.3M +8.5M +57.6% Mar 31, 2016 10-K 2017-07-14
Q4 2015 17.1M +3.6M +26.6% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 16.2M +3.97M +32.4% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 15M +2.5M +20% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 14.8M +5.39M +57.5% Mar 31, 2015 10-K 2016-07-14
Q4 2014 13.5M +5.54M +69.4% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 12.2M +4.77M +63.7% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 12.5M +5.46M +77.6% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 9.37M +2.39M +34.3% Mar 31, 2014 10-K 2015-07-14
Q4 2013 7.98M -52.1M -86.7% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 7.48M -52.6M -87.5% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 7.03M -53M -88.3% Jun 30, 2013 10-Q 2013-08-16
Q1 2013 6.98M +974K +16.2% Mar 31, 2013 10-K 2014-07-15
Q4 2012 60.1M +12.5M +26.2% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 60.1M +44M +273% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 60.1M +44M +273% Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 6.01M -8.88M -59.7% Mar 31, 2012 10-K/A 2014-07-15
Q4 2011 47.6M Dec 31, 2011 10-Q 2012-02-16
Q3 2011 16.1M Sep 30, 2011 10-Q 2011-11-18
Q2 2011 16.1M Jun 30, 2011 10-Q 2011-08-18
Q1 2011 14.9M +13.6M +1046% Mar 31, 2011 10-K 2012-07-16
Q1 2010 1.3M Mar 31, 2010 10-K 2016-07-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.